Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.
暂无分享,去创建一个
E. Cosson | P. Schaepelynck-Belicar | J. Attali | J. Pariés | E. Hamo-Tchatchouang | L. Dufaitre-Patouraux | Emmanuel Cosson
[1] Lutz Heinemann,et al. Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors , 2008, Diabetes Care.
[2] B. Braun,et al. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. , 2008, Diabetes research and clinical practice.
[3] R. Gerard. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. , 2008 .
[4] H. Lapinski,et al. Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? , 2007, Diabetes & metabolism.
[5] Bruce Buckingham,et al. Real-time continuous glucose monitoring , 2007, Current opinion in endocrinology, diabetes, and obesity.
[6] T. Rönnemaa,et al. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. , 2007, Diabetes research and clinical practice.
[7] A. Farmer,et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial , 2007, BMJ : British Medical Journal.
[8] T. Kubiak,et al. Microdialysis-based 48-hour continuous glucose monitoring with GlucoDay: clinical performance and patients' acceptance. , 2006, Diabetes technology & therapeutics.
[9] K. Dear,et al. Continuous Glucose Monitoring–Guided Insulin Adjustment in Children and Adolescents on Near-Physiological Insulin Regimens , 2006, Diabetes Care.
[10] P. Rossetti,et al. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. , 2006, Diabetes technology & therapeutics.
[11] H. Guess,et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single‐blind, randomized, controlled trial , 2006, Pediatric diabetes.
[12] Jean-Paul Cristol,et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.
[13] H Hanaire-Broutin,et al. Value and limitations of the Continuous Glucose Monitoring System in the management of type 1 diabetes. , 2006, Diabetes & metabolism.
[14] O. Kordonouri,et al. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[15] J Hans DeVries,et al. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. , 2005, Diabetes care.
[16] L. Bouter,et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.
[17] Kathryn Tan,et al. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)* , 2005, Current medical research and opinion.
[18] Claresa Levetan,et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. , 2004, Mayo Clinic proceedings.
[19] L. V. Van Gaal,et al. Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device , 2004, Diabetes/metabolism research and reviews.
[20] J. Silverstein,et al. Predictors of control of diabetes: monitoring may be the key. , 2004, The Journal of pediatrics.
[21] P. Schaepelynck-Belicar,et al. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). , 2003, Diabetes & metabolism.
[22] F Valgimigli,et al. A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 2). , 2003, Biosensors & bioelectronics.
[23] Johnny Ludvigsson,et al. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. , 2003, Pediatrics.
[24] A. Novials,et al. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. , 2003, Diabetes care.
[25] R. Schiaffini,et al. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk , 2002, Diabetes/metabolism research and reviews.
[26] Alberto Maran,et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. , 2002, Diabetes care.
[27] W. Tamborlane,et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. , 2001, Diabetes care.
[28] Jennifer Y. Liu,et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.
[29] H. Chase,et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. , 2001, Pediatrics.
[30] B P Kovatchev,et al. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. , 1998, Diabetes care.
[31] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[32] M. Engelgau,et al. Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S , 1998, Diabetes Care.
[33] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[34] W. F. Taylor,et al. Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.
[35] J. Schlichtkrull,et al. [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS]. , 1964, Ugeskrift for laeger.
[36] L. Monnier,et al. Contributions of fasting and postprandial glucose to hemoglobin A1c. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[37] A. Ceriello. Postprandial hyperglycemia and diabetes complications: is it time to treat? , 2005, Diabetes.
[38] M. Hanefeld,et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. , 2004, European heart journal.